• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors

tetano

Editor, Senior Moderator
Eur J Med Chem. 2018 Sep 27;159:206-216. doi: 10.1016/j.ejmech.2018.09.065. [Epub ahead of print]
[h=1]Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.[/h] Yu Y[SUP]1[/SUP], Tang Q[SUP]2[/SUP], Xu Z[SUP]1[/SUP], Li S[SUP]2[/SUP], Jin M[SUP]1[/SUP], Zhao Z[SUP]2[/SUP], Dong C[SUP]1[/SUP], Wu S[SUP]3[/SUP], Zhou HB[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H5N1 virus, one subtype of highly pathogenic influenza A virus in human infection, has recently received attention due to its unpredictable and high mortality. In this study, a series of arylsulfonamide derivatives were identified as improved H5N1 inhibitors for the influenza treatment by systematic structure-activity relationship investigation. Among them, the most potent H5N1 inhibitor 3h exhibited excellent antiviral activity against H5N1 virus with EC[SUB]50[/SUB] value of 0.006 μM and selectivity index 33543.3. Moreover, the molecular docking of 3h with M2 proton channel protein provides practical way for understanding the inhibition of H5N1 with this kind of compounds.


[h=4]KEYWORDS:[/h] Arylsulfonamide inhibitors; H5N1 virus; High mortality; Structure-activity relationship

PMID: 30292897 DOI: 10.1016/j.ejmech.2018.09.065
 
Back
Top Bottom